Medtronic (NYSE:MDT) announced today that the FDA approved its next-generation SynchroMed III intrathecal drug delivery system. The medtech giant designed SynchroMed III to treat patients with chronic pain, cancer pain and severe spasticity. The targeted drug delivery (TDD) system alleviates symptoms by delivering medication directly to the fluid surrounding the spinal cord. SynchroMed III builds upon […]
Medtronic warns on previous software MiniMed 780G in Germany
Medtronic (NYSE:MDT) issued an urgent field safety notice in Germany to warn of a potential issue with its MiniMed 780G system. MiniMed 780G, Medtronic’s next-generation automated insulin delivery system, has been available in Europe since earning CE mark in mid-2020. In March 2021, the company first communicated that its pumps with software version 6.5 could […]
New data shows consistency of Medtronic MiniMed 780G in different demos, cultures
Medtronic (NYSE:MDT) today announced real-world data demonstrating the global consistency of its MiniMed 780G automated insulin delivery system. The data, according to Medtronic, demonstrates that using the system allows people with diabetes to meet or exceed internationally recommended targets regardless of location. The medtech giant says a barrier to automated insulin delivery (AID) adoption and […]
Dexcom launches next-gen G7 CGM in Canada
Dexcom (Nasdaq:DXCM) today announced the commercial launch of its next-generation G7 continuous glucose monitor (CGM) in Canada. The San Diego-based company expects to make its latest CGM technology available to Canadians on Oct. 10, 2023. It covers people with all types of diabetes aged two and older, including those who are pregnant, in the country. […]
Insulet CFO departs for same post at 3M’s Health Care spinoff
Insulet (Nasdaq:PODD) announced today that Wayde McMillan decided to leave his role as EVP, CFO and treasurer. McMillan’s departure goes into effect on Oct. 20, 2023. He intends to join 3M as CFO of its Health Care business, which the company expects to spin off late this year or early next year. President and CEO […]
Phillips-Medisize, GlucoModicum partner on needle-free CGM
Molex company Phillips-Medisize today announced a partnership with GlucoModicum to design a new continuous glucose monitor (CGM). The companies teamed up to design and eventually commercialize a proprietary, non-invasive, wearable CGM device. They aim to remove the technology and patient-care roadblocks that exist within continuous glucose monitoring. Phillips-Medisize develops drug delivery, in vitro diagnostic and […]
Abbott study says FreeStyle Libre users on insulin show lower HbA1c levels
Abbott (NYSE:ABT) today announced real-world data associating its FreeStyle Libre CGM with significant HbA1c reductions. The continuous glucose monitor (CGM) played a part in significant reductions in HbA1c, the average glucose levels over a three-month period. It was also associated with a lower rate of hospitalization for people with type 2 diabetes on both multiple […]
Cordis acquires drug-eluting balloon maker MedAlliance for up to $1.135B
MedAlliance announced today that Cordis acquired it for a total consideration that could reach up to $1.135 billion. The companies initially announced the planned deal in October of last year. Cordis, which develops interventional cardiovascular and endovascular technologies, made a $35 million investment last year. Its upfront closing payment totals $200 million, with achievement milestones […]
FDA approves wearable injector from Enable Injections
Enable Injections announced today that it received FDA approval for its enFuse injector for the delivery of Empaveli. Empaveli, commercialized by Apellis Pharmaceuticals, treats adults with paroxysmal nocturnal hemoglobinuria (PNH). The injector — in this case, called the Empaveli Injector — offers self-administration of the pharmaceutical. The compact, wearable device streamlines the self-administration experience with […]
Ypsomed has a new CFO, board member
Ypsomed announced today that it selected Samuel Künzli to take over the company’s chief financial officer (CFO) position. Niklaus Ramseier elected to hand over the reins to the CFO position after more than 20 years in the post. The transition begins on March 31, 2024, with Ramseier remaining available to the drug delivery device maker […]